UPDATED POPULATION PHARMACOKINETIC ANALYSIS FOR NEW DOSING REGIMENS OF RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PEDIATRIC PATIENTS WITH HEMOPHILIA B.

Zhang Y.; McKeand W.; Roberts J.; Goldstein B.; Tortorici M.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >UPDATED POPULATION PHARMACOKINETIC ANALYSIS FOR NEW DOSING REGIMENS OF RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PEDIATRIC PATIENTS WITH HEMOPHILIA B.

【24h】

UPDATED POPULATION PHARMACOKINETIC ANALYSIS FOR NEW DOSING REGIMENS OF RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PEDIATRIC PATIENTS WITH HEMOPHILIA B.

机译：血友病患者中成人和儿科患者重组凝血因子IX白蛋白融合蛋白（RIX-FP）的新剂量药代动力学分析。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2020年第s1期|共1页
作者
Zhang Y.; McKeand W.; Roberts J.; Goldstein B.; Tortorici M.;
展开▼
作者单位

CSL Behring King Of Prussia PA USA;

CSL Behring King Of Prussia PA USA;

CSL Behring King Of Prussia PA USA;

CSL Behring King Of Prussia PA USA;

CSL Behring King Of Prussia PA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
入库时间 2022-08-19 23:48:02

相似文献

外文文献
中文文献
专利

1. UPDATED POPULATION PHARMACOKINETIC ANALYSIS FOR NEW DOSING REGIMENS OF RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PEDIATRIC PATIENTS WITH HEMOPHILIA B. [J] . Zhang Y., McKeand W., Roberts J., Clinical Pharmacology and Therapeutics . 2020,第S1期

机译：血友病患者中成人和儿科患者重组凝血因子IX白蛋白融合蛋白（RIX-FP）的新剂量药代动力学分析。
2. Transforming the treatment for hemophilia B patients: update on the clinical development of recombinant fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP) [J] . Santagostino Elena Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2016,第Suppla3期

机译：改变血友病B患者的治疗方法：将重组凝血因子IX与重组白蛋白（rIX-FP）连接的重组融合蛋白的临床开发进展
3. Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients [J] . SantagostinoE., NegrierC., KlamrothR., Blood: The Journal of the American Society of Hematology . 2012,第12期

机译：连接凝血因子IX与白蛋白（rIX-FP）的新型重组融合蛋白在B型血友病患者中的安全性和药代动力学
4. ANALYSIS OF N-LINKED GLYCANS FROM COAGULATION FACTOR IX, RECOMBINANT AND PLASMA DERIVED, USING HILIC LC/FLR/QTOF MS [C] . Ying Qing Yu, Weibin Chen, Martin Gilar, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：用HILIC LC / FLR / QTOF MS分析来自凝血因子IX，重组和血浆衍生的N-连接的聚糖
5. Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients [O] . Elena Santagostino, Claude Negrier, Robert Klamroth, -1

机译：连接凝血因子IX与白蛋白（rIX-FP）的新型重组融合蛋白在B型血友病患者中的安全性和药代动力学
6. Transforming the treatment for hemophilia B patients: update on the clinical development of recombinant fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP) [O] . Santagostino Elena 2016

机译：改变血友病B患者的治疗方法：将重组凝血因子IX与重组白蛋白（rIX-FP）连接在一起的重组融合蛋白的临床开发进展

UPDATED POPULATION PHARMACOKINETIC ANALYSIS FOR NEW DOSING REGIMENS OF RECOMBINANT COAGULATION FACTOR IX ALBUMIN FUSION PROTEIN (RIX-FP) IN ADULT AND PEDIATRIC PATIENTS WITH HEMOPHILIA B.

著录项

相似文献

相关主题

期刊订阅